Group 1 - The company, Tibet Qizheng Tibetan Medicine Co., Ltd., announced the conversion situation of its convertible bonds for the first quarter of 2025 [1] - The convertible bonds were issued with a total amount of 800 million yuan, with a face value of 100 yuan per bond, and began trading on October 27, 2020 [1][2] - The conversion price for the bonds has been adjusted multiple times, currently set at 19.39 yuan per share [1][2][3] Group 2 - As of March 31, 2025, the total number of shares converted from the convertible bonds is 939,740 shares, with a remaining bond balance of 781,358,000 yuan [6][7] - The company's total share capital increased by 256 shares in the first quarter of 2025, resulting in a total share capital of 531,085,974 shares [7][8] - The structure of the company's shares includes 1,128,408 locked shares and 529,957,566 freely tradable shares, maintaining the same proportions before and after the conversion [7]
奇正藏药: 关于2025年第一季度可转换公司债券转股情况的公告